(Q28205016)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12955285%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

review article

1 reference

title

NMDA receptor antagonist effects, cortical glutamatergic function, and schizophrenia: toward a paradigm shift in medication development (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12955285%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

0 references

1 reference

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12955285%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12955285%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

John H Krystal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12955285%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

D Cyril D'Souza

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12955285%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

Edward Perry

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12955285%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

Ralph Hoffman

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12955285%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

language of work or name

English

0 references

publication date

2 September 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12955285%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

number of pages

1 reference

inferred from page(s)

published in

Psychopharmacology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12955285%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

volume

169

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12955285%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

issue

3-4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12955285%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

page(s)

215-233

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12955285%20AND%20SRC:MED&resulttype=core&format=json

Structural abnormalities of subicular dendrites in subjects with schizophrenia and mood disorders: preliminary findings

7 November 2019

cites work

1 reference

12 December 2020

Preliminary evidence of improved verbal working memory performance and normalization of task-related frontal lobe activation in schizophrenia following cognitive exercises.

1 reference

12 December 2020

Differential plasma membrane distribution of metabotropic glutamate receptors mGluR1 alpha, mGluR2 and mGluR5, relative to neurotransmitter release sites

1 reference

12 December 2020

A role for NMDA-receptor channels in working memory.

1 reference

12 December 2020

Dopamine D1 receptor-dependent trafficking of striatal NMDA glutamate receptors to the postsynaptic membrane.

1 reference

12 December 2020

Lithium vs carbamazepine in the maintenance treatment of schizoaffective disorder: a randomised study

1 reference

12 December 2020

D-serine added to clozapine for the treatment of schizophrenia

1 reference

12 December 2020

Activation of metabotropic glutamate receptor 5 has direct excitatory effects and potentiates NMDA receptor currents in neurons of the subthalamic nucleus.

1 reference

12 December 2020

A neurohistological correlate of schizophrenia

1 reference

12 December 2020

[Increased 3H-muscimol binding in post-mortem brains of chronic schizophrenics]

1 reference

12 December 2020

Lamotrigine and carbamazepine affect differently the release of D-[3H]aspartate from mouse cerebral cortex slices: involvement of NO.

1 reference

12 December 2020

A test of the transmethylation hypothesis in acute schizophrenic patients

1 reference

12 December 2020

The schizophrenia ketamine challenge study debate.

1 reference

12 December 2020

Can adults with attention-deficit/hyperactivity disorder be distinguished from those with comorbid bipolar disorder? Findings from a sample of clinically referred adults

1 reference

12 December 2020

Evidence of dysfunction of a prefrontal-limbic network in schizophrenia: a magnetic resonance imaging and regional cerebral blood flow study of discordant monozygotic twins

1 reference

12 December 2020

Resting Cerebral Glucose Metabolism in First-Episode and Previously Treated Patients With Schizophrenia Relates to Clinical Features

1 reference

12 December 2020

Glycine neurotransmitter transporters: an update

1 reference

12 December 2020

Maldistribution of interstitial neurons in prefrontal white matter of the brains of schizophrenic patients

1 reference

12 December 2020

Reduced frontotemporal functional connectivity in schizophrenia associated with auditory hallucinations

1 reference

12 December 2020

Controlled, dose-response study of sertindole and haloperidol in the treatment of schizophrenia. Sertindole Study Group

1 reference

12 December 2020

Distorted distribution of nicotinamide-adenine dinucleotide phosphate-diaphorase neurons in temporal lobe of schizophrenics implies anomalous cortical development

1 reference

12 December 2020

Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine

1 reference

12 December 2020

Increased cortical kynurenate content in schizophrenia

1 reference

12 December 2020

Rapid, experience-dependent expression of synaptic NMDA receptors in visual cortex in vivo

1 reference

12 December 2020

An association between reduced interhemispheric EEG coherence in the temporal lobe and genetic risk for schizophrenia

1 reference

12 December 2020

Distribution of glutamate decarboxylase65 immunoreactive puncta on pyramidal and nonpyramidal neurons in hippocampus of schizophrenic brain

1 reference

12 December 2020

GABAergic local circuit neurons and prefrontal cortical dysfunction in schizophrenia

1 reference

12 December 2020

Progressive brain volume changes and the clinical course of schizophrenia in men: a longitudinal magnetic resonance imaging study

1 reference

12 December 2020

Up-regulation of GABAA receptor binding on neurons of the prefrontal cortex in schizophrenic subjects

1 reference

12 December 2020

Antagonism of phencyclidine-induced hyperactivity by glycine in mice

1 reference

12 December 2020

Kinetic study of the interactions between the glutamate and glycine recognition sites on the N-methyl-D-aspartic acid receptor complex

1 reference

12 December 2020

Reversal of phencyclidine effects by a group II metabotropic glutamate receptor agonist in rats

1 reference

12 December 2020

Proton magnetic resonance spectroscopy in schizophrenia

1 reference

12 December 2020

The functional consequences of memory impairments on initial work performance in people with schizophrenia.

1 reference

12 December 2020

NMDA-dependent modulation of CA1 local circuit inhibition.

1 reference

12 December 2020

Association of ketamine-induced psychosis with focal activation of the prefrontal cortex in healthy volunteers

1 reference

12 December 2020

Activation of glutamatergic neurotransmission by ketamine: a novel step in the pathway from NMDA receptor blockade to dopaminergic and cognitive disruptions associated with the prefrontal cortex

1 reference

12 December 2020

The relation between funding by the National Institutes of Health and the burden of disease

1 reference

12 December 2020

The treatment of negative symptoms: pharmacological and methodological issues

1 reference

12 December 2020

NMDA agonists and antagonists as probes of glutamatergic dysfunction and pharmacotherapies in neuropsychiatric disorders

1 reference

12 December 2020

Schizophrenia and glutamatergic transmission

1 reference

12 December 2020

Destruction and creation of spatial tuning by disinhibition: GABA(A) blockade of prefrontal cortical neurons engaged by working memory.

1 reference

12 December 2020

A double-blind study of adjunctive carbamazepine versus placebo on excited states of schizophrenic and schizoaffective disorders.

1 reference

12 December 2020

Neuropsychological impairment with schizophrenia vs. acute and chronic cerebral lesions

1 reference

12 December 2020

1 reference

12 December 2020

Phencyclidine increases forebrain monoamine metabolism in rats and monkeys: modulation by the isomers of HA966.

1 reference

12 December 2020

Psychosis: pathological activation of limbic thalamocortical circuits by psychomimetics and schizophrenia?

1 reference

12 December 2020

EEG coherence of prefrontal areas in normal and schizophrenic males during perceptual activation

1 reference

12 December 2020

Ketamine activates psychosis and alters limbic blood flow in schizophrenia.

1 reference

12 December 2020

Transcranial magnetic stimulation of left temporoparietal cortex and medication-resistant auditory hallucinations.

1 reference

12 December 2020

Preliminary experience with an ampakine (CX516) as a single agent for the treatment of schizophrenia: a case series

1 reference

12 December 2020

Schizophrenia is associated with elevated amphetamine-induced synaptic dopamine concentrations: evidence from a novel positron emission tomography method

1 reference

12 December 2020

Carbamazepine maintenance treatment in outpatient schizophrenics

1 reference

12 December 2020

Brain activations in schizophrenia during a graded memory task studied with functional neuroimaging

1 reference

12 December 2020

EEG coherence during hemispheric activation in schizophrenics

1 reference

12 December 2020

Altered synaptophysin expression as a marker of synaptic pathology in schizophrenia

1 reference

12 December 2020

Design, synthesis, and biological activity of a potent inhibitor of the neuropeptidase N-acetylated alpha-linked acidic dipeptidase

1 reference

12 December 2020

Pharmacotherapy of chronic hospitalized schizophrenics: prescription practices

1 reference

12 December 2020

D-serine as a neuromodulator: regional and developmental localizations in rat brain glia resemble NMDA receptors.

1 reference

12 December 2020

Cortical-striatal-thalamic circuits and brain glucose metabolic activity in 70 unmedicated male schizophrenic patients

1 reference

12 December 2020

Cognitive correlates of job tenure among patients with severe mental illness.

1 reference

12 December 2020

Experience-induced neurogenesis in the senescent dentate gyrus.

1 reference

12 December 2020

Smaller neuron size in schizophrenia in hippocampal subfields that mediate cortical-hippocampal interactions

1 reference

12 December 2020

Ketamine-induced exacerbation of psychotic symptoms and cognitive impairment in neuroleptic-free schizophrenics.

1 reference

12 December 2020

Effect of carbamazepine, oxcarbazepine and lamotrigine on the increase in extracellular glutamate elicited by veratridine in rat cortex and striatum

1 reference

12 December 2020

Ketamine and fMRI BOLD signal: distinguishing between effects mediated by change in blood flow versus change in cognitive state

1 reference

12 December 2020

Psychedelic effects of ketamine in healthy volunteers: relationship to steady-state plasma concentrations

1 reference

12 December 2020

A functional neuroanatomy of hallucinations in schizophrenia

1 reference

12 December 2020

Unveiling the functions of presynaptic metabotropic glutamate receptors in the central nervous system

1 reference

12 December 2020

THE BRAIN'S RECORD OF AUDITORY AND VISUAL EXPERIENCE. A FINAL SUMMARY AND DISCUSSION

1 reference

12 December 2020

Morphometric evidence for neuronal and glial prefrontal cell pathology in major depression

1 reference

12 December 2020

Gene expression for glutamic acid decarboxylase is reduced without loss of neurons in prefrontal cortex of schizophrenics.

1 reference

12 December 2020

No hypofrontality in schizophrenia demonstrated by positron emission tomography

1 reference

12 December 2020

Lamotrigine--clozapine combination in refractory schizophrenia: three cases

1 reference

12 December 2020

A negative, double-blind, placebo-controlled, clinical trial of verapamil in chronic schizophrenia

1 reference

12 December 2020

Activation of metabotropic glutamate receptor 1 accelerates NMDA receptor trafficking

1 reference

12 December 2020

Reciprocal alterations in pre- and postsynaptic inhibitory markers at chandelier cell inputs to pyramidal neurons in schizophrenia

1 reference

12 December 2020

Clinical and theoretical implications of 5-HT2 and D2 receptor occupancy of clozapine, risperidone, and olanzapine in schizophrenia

1 reference

12 December 2020

Mechanisms of calcium influx into hippocampal spines: heterogeneity among spines, coincidence detection by NMDA receptors, and optical quantal analysis.

1 reference

12 December 2020

Ketamine-induced NMDA receptor hypofunction as a model of memory impairment and psychosis.

1 reference

12 December 2020

Modulation of N-methyl-D-aspartate receptor function by glycine transport

1 reference

12 December 2020

Distinct mechanism for antidepressant activity by blockade of central substance P receptors

1 reference

12 December 2020

Neurophysiological evidence of corollary discharge dysfunction in schizophrenia

1 reference

12 December 2020

Regional Brain Function in Schizophrenia

1 reference

12 December 2020

Experience-dependent regulation of adult hippocampal neurogenesis: effects of long-term stimulation and stimulus withdrawal

1 reference

12 December 2020

The NMDA antagonist model for schizophrenia: promise and pitfalls.

1 reference

12 December 2020

Does risperidone improve verbal working memory in treatment-resistant schizophrenia?

1 reference

12 December 2020

Lamotrigine inhibits Ca2+ currents in cortical neurons: functional implications

1 reference

12 December 2020

Pharmacokinetics of ketamine in man

1 reference

12 December 2020

Deficits in Small Interneurons in Prefrontal and Cingulate Cortices of Schizophrenic and Schizoaffective Patients

1 reference

12 December 2020

Slow transcranial magnetic stimulation, long-term depotentiation, and brain hyperexcitability disorders

1 reference

12 December 2020

NMDA receptor regulation of memory and behavior in humans

1 reference

12 December 2020

Carbamazepine as an adjunct of antipsychotic therapy

1 reference

12 December 2020

Preliminary evidence of attenuation of the disruptive effects of the NMDA glutamate receptor antagonist, ketamine, on working memory by pretreatment with the group II metabotropic glutamate receptor agonist, LY354740, in healthy human subjects

1 reference

12 December 2020

Effects of verapamil on tardive dyskinesia and psychosis in schizophrenic patients

1 reference

12 December 2020

Control of NMDA receptor activation by a glycine transporter co-expressed in Xenopus oocytes

1 reference

12 December 2020

Prefrontal cortex and schizophrenia. A quantitative magnetic resonance imaging study

1 reference

12 December 2020

No evidence of altered in vivo benzodiazepine receptor binding in schizophrenia

1 reference

12 December 2020

Schizophrenia and the parvalbumin-containing class of cortical local circuit neurons

1 reference

12 December 2020

Dendritic spine density in schizophrenia and depression

1 reference

12 December 2020

A clinical trial of nifedipine in schizophrenia and tardive dyskinesia

1 reference

12 December 2020

Attenuation of ketamine effects by nimodipine pretreatment in recovering ethanol dependent men: psychopharmacologic implications of the interaction of NMDA and L-type calcium channel antagonists

1 reference

12 December 2020

Placebo-controlled study of the D4/5-HT2A antagonist fananserin in the treatment of schizophrenia

1 reference

12 December 2020

Neuropsychological deficits in neuroleptic naive patients with first-episode schizophrenia

1 reference

12 December 2020

Intramuscular ketamine for pediatric sedation in the emergency department: safety profile in 1,022 cases

1 reference

12 December 2020

Increased baseline occupancy of D2 receptors by dopamine in schizophrenia

1 reference

12 December 2020

Expression mechanisms underlying NMDA receptor-dependent long-term potentiation

1 reference

12 December 2020

A placebo-controlled trial of D-cycloserine added to conventional neuroleptics in patients with schizophrenia

1 reference

12 December 2020

Lamotrigine may limit pathological excitation in the hippocampus by modulating a transient potassium outward current

1 reference

12 December 2020

Risperidone in the treatment of schizophrenia

1 reference

12 December 2020

N-methyl-D-aspartate receptor hypofunction in schizophrenia could arise from reduced cortical connectivity rather than receptor dysfunction

1 reference

12 December 2020

Comparative pharmacology of bipolar disorder and schizophrenia

1 reference

12 December 2020

Experiential phenomena of temporal lobe epilepsy. Facts and hypotheses

1 reference

12 December 2020

A dopamine/D1 receptor/protein kinase A/dopamine- and cAMP-regulated phosphoprotein (Mr 32 kDa)/protein phosphatase-1 pathway regulates dephosphorylation of the NMDA receptor.

1 reference

12 December 2020

Local circuit neurons of the prefrontal cortex in schizophrenia: selective increase in the density of calbindin-immunoreactive neurons.

1 reference

12 December 2020

Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses

1 reference

12 December 2020

Effect of divalproex combined with olanzapine or risperidone in patients with an acute exacerbation of schizophrenia

1 reference

12 December 2020

Ketamine: an update on the first twenty-five years of clinical experience

1 reference

12 December 2020

Correlation between reduced in vivo benzodiazepine receptor binding and severity of psychotic symptoms in schizophrenia

1 reference

12 December 2020

Uncinate fasciculus findings in schizophrenia: a magnetic resonance diffusion tensor imaging study

1 reference

12 December 2020

Neural models of normal and abnormal behavior: what do schizophrenia, parkinsonism, attention deficit disorder, and depression have in common?

1 reference

12 December 2020

Ziprasidone 80 mg/day and 160 mg/day in the acute exacerbation of schizophrenia and schizoaffective disorder: a 6-week placebo-controlled trial. Ziprasidone Study Group

1 reference

12 December 2020

Interactions between the glutamate and glycine recognition sites of the N-methyl-D-aspartate receptor from rat brain, as revealed from radioligand binding studies

1 reference

12 December 2020

Ketamine: a review of its pharmacologic properties and use in ambulatory anesthesia

1 reference

12 December 2020

Characterization of typical and atypical antipsychotic drugs based on in vivo occupancy of serotonin2 and dopamine2 receptors

1 reference

12 December 2020

D-serine and the therapeutic challenge posed by the N-methyl-D-aspartate antagonist model of schizophrenia

1 reference

12 December 2020

Mapping adolescent brain change reveals dynamic wave of accelerated gray matter loss in very early-onset schizophrenia

1 reference

12 December 2020

A systems model of altered consciousness: integrating natural and drug-induced psychoses

1 reference

12 December 2020

Translating the basic and clinical cognitive neuroscience of schizophrenia to drug development and clinical trials of antipsychotic medications

1 reference

12 December 2020

Reversal of phencyclidine-induced hyperactivity by glycine and the glycine uptake inhibitor glycyldodecylamide

1 reference

12 December 2020

Serotonin-dopamine antagonists and treatment of negative symptoms

1 reference

12 December 2020

Compromised white matter tract integrity in schizophrenia inferred from diffusion tensor imaging

1 reference

12 December 2020

Coupling of mGluR/Homer and PSD-95 complexes by the Shank family of postsynaptic density proteins

1 reference

12 December 2020

Member of the Ampakine class of memory enhancers prolongs the single channel open time of reconstituted AMPA receptors.

1 reference

12 December 2020

A two-process theory of schizophrenia: evidence from studies in post-mortem brain

1 reference

12 December 2020

Amelioration of negative symptoms in schizophrenia by glycine.

1 reference

12 December 2020

Some normal and abnormal behavioral syndromes due to transmitter gating of opponent processes

1 reference

12 December 2020

Lamotrigine prevents ketamine but not amphetamine-induced deficits in prepulse inhibition in mice

1 reference

12 December 2020

Does ketamine-mediated N-methyl-D-aspartate receptor antagonism cause schizophrenia-like oculomotor abnormalities?

1 reference

12 December 2020

Environmental enrichment inhibits spontaneous apoptosis, prevents seizures and is neuroprotective

1 reference

12 December 2020

The neuropathology of schizophrenic diseases: historical aspects and present knowledge

1 reference

12 December 2020

A comparison of clozapine and haloperidol in hospitalized patients with refractory schizophrenia. Department of Veterans Affairs Cooperative Study Group on Clozapine in Refractory Schizophrenia.

1 reference

12 December 2020

N-methyl-d-aspartate receptors regulate 5-HT release in the raphe nuclei and frontal cortex of freely moving rats: differential role of 5-HT1A autoreceptors

1 reference

12 December 2020

GABAergic interneurons: implications for understanding schizophrenia and bipolar disorder

1 reference

12 December 2020

Creation of a constitutively activated state of the 5-hydroxytryptamine2A receptor by site-directed mutagenesis: inverse agonist activity of antipsychotic drugs.

1 reference

12 December 2020

Interactive effects of subanesthetic ketamine and haloperidol in healthy humans

1 reference

12 December 2020

Increased frontal and reduced parietal glucose metabolism in acute untreated schizophrenia

1 reference

12 December 2020

Clozapine plus lamotrigine in treatment-resistant schizophrenia.

1 reference

12 December 2020

Cortical responsiveness during inner speech in schizophrenia: an event-related potential study

1 reference

12 December 2020

Subtype progression and pathophysiologic deterioration in early schizophrenia

1 reference

12 December 2020

The density and spatial distribution of GABAergic neurons, labelled using calcium binding proteins, in the anterior cingulate cortex in major depressive disorder, bipolar disorder, and schizophrenia.

1 reference

12 December 2020

The anatomy of conscious vision: an fMRI study of visual hallucinations

1 reference

12 December 2020

Trait and state aspects of P300 amplitude reduction in schizophrenia: a retrospective longitudinal study

1 reference

12 December 2020

The glutamate synapse in neuropsychiatric disorders. Focus on schizophrenia and Alzheimer's disease

1 reference

12 December 2020

Increase in meso-prefrontal dopaminergic activity after stimulation of CB1 receptors by cannabinoids

1 reference

12 December 2020

Cortical gray matter volume deficits in schizophrenia: a replication

1 reference

12 December 2020

Systemic PCP treatment elevates brain extracellular 5-HT: a microdialysis study in awake rats

1 reference

12 December 2020

Ketamine in cancer pain: an update

1 reference

12 December 2020

Isodirectional tuning of adjacent interneurons and pyramidal cells during working memory: evidence for microcolumnar organization in PFC.

1 reference

12 December 2020

Prefrontal and temporal blood flow in schizophrenia: resting and activation technetium-99m-HMPAO SPECT patterns in young neuroleptic-naive patients with acute disease

1 reference

12 December 2020

Symptoms, cognitive functioning, and adaptive skills in geriatric patients with lifelong schizophrenia: a comparison across treatment sites

1 reference

12 December 2020

PHARMACOLOGIC EFFECTS OF CI-581, A NEW DISSOCIATIVE ANESTHETIC, IN MAN.

1 reference

12 December 2020

Parvalbumin-immunoreactive neurons are reduced in the prefrontal cortex of schizophrenics

1 reference

12 December 2020

Control of feedforward dendritic inhibition by NMDA receptor-dependent spike timing in hippocampal interneurons.

1 reference

12 December 2020

Dose-finding trial of D-cycloserine added to neuroleptics for negative symptoms in schizophrenia

1 reference

12 December 2020

Inhibition of N-type calcium currents by lamotrigine in rat amygdalar neurones

1 reference

12 December 2020

Expression and initial characterization of a soluble glycine binding domain of the N-methyl-D-aspartate receptor NR1 subunit

1 reference

12 December 2020

Augmenting antipsychotic treatment with lamotrigine or topiramate in patients with treatment-resistant schizophrenia: a naturalistic case-series outcome study

1 reference

12 December 2020

Hallucinogenic drug induced states resemble acute endogenous psychoses: results of an empirical study

1 reference

12 December 2020

Proton magnetic resonance spectroscopy in the frontal and temporal lobes of neuroleptic naive patients with schizophrenia

1 reference

12 December 2020

Hypofrontality in schizophrenia: distributed dysfunctional circuits in neuroleptic-naïve patients

1 reference

12 December 2020

Ketamine infusions: pharmacokinetics and clinical effects

1 reference

12 December 2020

Performance on the Wisconsin Card Sorting Test as a Predictor of Rehospitalization in Schizophrenia

1 reference

12 December 2020

Clozapine's effectiveness for patients in state hospitals: results from a randomized trial.

1 reference

12 December 2020

Association between smaller left posterior superior temporal gyrus volume on magnetic resonance imaging and smaller left temporal P300 amplitude in first-episode schizophrenia

1 reference

12 December 2020

High-throughput screening of historic collections: observations on file size, biological targets, and file diversity

1 reference

12 December 2020

The glutamatergic dysfunction hypothesis for schizophrenia

1 reference

12 December 2020

Gamma frequency-range abnormalities to auditory stimulation in schizophrenia

1 reference

12 December 2020

Reduction of synaptophysin immunoreactivity in the prefrontal cortex of subjects with schizophrenia. Regional and diagnostic specificity

1 reference

12 December 2020

Glutamate receptor expression in schizophrenic brain

1 reference

12 December 2020

Efficacy of high-dose glycine in the treatment of enduring negative symptoms of schizophrenia

1 reference

12 December 2020

Altered GABA neurotransmission and prefrontal cortical dysfunction in schizophrenia

1 reference

12 December 2020

Glutamate and GABA systems as targets for novel antidepressant and mood-stabilizing treatments

1 reference

12 December 2020

Multiple sclerosis: altered glutamate homeostasis in lesions correlates with oligodendrocyte and axonal damage

1 reference

12 December 2020

Aripiprazole, a novel antipsychotic, is a high-affinity partial agonist at human dopamine D2 receptors

1 reference

12 December 2020

Gamma activity in schizophrenia: evidence of impaired network binding?

1 reference

12 December 2020

Voltage-activated calcium channels: targets of antiepileptic drug therapy?

1 reference

12 December 2020

Severity of symptoms in chronically institutionalized geriatric schizophrenic patients.

1 reference

12 December 2020

Altered distribution of parvalbumin-immunoreactive local circuit neurons in the anterior cingulate cortex of schizophrenic patients

1 reference

12 December 2020

Correlates of long-term unemployment among inner-city adults with serious and persistent mental illness.

1 reference

12 December 2020

Mechanism and impact of allosteric AMPA receptor modulation by the ampakine CX546.

1 reference

12 December 2020

Receptor mechanisms and circuitry underlying NMDA antagonist neurotoxicity

1 reference

12 December 2020

Neurocognitive enhancement therapy with work therapy: effects on neuropsychological test performance

1 reference

12 December 2020

Efficacy and safety of aripiprazole and haloperidol versus placebo in patients with schizophrenia and schizoaffective disorder.

1 reference

12 December 2020

Glutamate agonist activity: implications for antipsychotic drug action and schizophrenia.

1 reference

12 December 2020

A double-blind trial of carbamazepine in negative symptom schizophrenia.

1 reference

12 December 2020

Changes in serotonin2A and GABA(A) receptors in schizophrenia: studies on the human dorsolateral prefrontal cortex

1 reference

12 December 2020

Differential psychopathology and patterns of cerebral glucose utilisation produced by (S)- and (R)-ketamine in healthy volunteers using positron emission tomography (PET)

1 reference

12 December 2020

Placebo-controlled trial of glycine added to clozapine in schizophrenia

1 reference

12 December 2020

Immunohistochemical localization of gamma-aminobutyric acid(B) receptor in the hippocampus of subjects with schizophrenia

1 reference

12 December 2020

Opposite effects of high and low frequency rTMS on regional brain activity in depressed patients

1 reference

12 December 2020

Altered distribution of nicotinamide-adenine dinucleotide phosphate-diaphorase cells in frontal lobe of schizophrenics implies disturbances of cortical development.

1 reference

12 December 2020

Single photon emission computerized tomography imaging of amphetamine-induced dopamine release in drug-free schizophrenic subjects

1 reference

12 December 2020

Neuronal and glial somal size in the prefrontal cortex: a postmortem morphometric study of schizophrenia and Huntington disease

1 reference

12 December 2020

The nagging question of the function of N-acetylaspartylglutamate

1 reference

12 December 2020

The effects of a selective D4 dopamine receptor antagonist (L-745,870) in acutely psychotic inpatients with schizophrenia. D4 Dopamine Antagonist Group

1 reference

12 December 2020

Study of a new schizophrenomimetic drug; sernyl.

1 reference

12 December 2020

Blockade of neurotensin receptors suppresses the dopamine D1/D2 synergism on immediate early gene expression in the rat brain

1 reference

12 December 2020

Effect of clozapine and adjunctive high-dose glycine in treatment-resistant schizophrenia.

1 reference

12 December 2020

Reduced GABA uptake sites in the temporal lobe in schizophrenia

1 reference

12 December 2020

"Psychedelic" Experiences in Acute Psychoses

1 reference

12 December 2020

D-serine, an endogenous synaptic modulator: localization to astrocytes and glutamate-stimulated release

1 reference

12 December 2020

Physiologic dysfunction of dorsolateral prefrontal cortex in schizophrenia. I. Regional cerebral blood flow evidence

1 reference

12 December 2020

Activation of Heschl's gyrus during auditory hallucinations

1 reference

12 December 2020

Effects of ketamine in normal and schizophrenic volunteers

1 reference

12 December 2020

Utilization of valproate: extent of inpatient use in the New York State Office of Mental Health.

1 reference

12 December 2020

Nifedipine in the treatment of tardive dyskinesia

1 reference

12 December 2020

Neuregulin 1 and susceptibility to schizophrenia

1 reference

12 December 2020

D-serine added to antipsychotics for the treatment of schizophrenia

1 reference

12 December 2020

Delta9-tetrahydrocannabinol acts as a partial agonist to modulate glutamatergic synaptic transmission between rat hippocampal neurons in culture

1 reference

12 December 2020

Neuropsychological functioning as a moderator of the relationship between psychosocial functioning and the subjective experience of self and life in schizophrenia

1 reference

12 December 2020

High-throughout screening in combinatorial chemistry for drug discovery

1 reference

12 December 2020

The "pink spot", 3,4-dimethoxyphenylethylamine and dopamine. Relationship to Parkinson's disease and to schizophrenia.

1 reference

12 December 2020

Diffusion tensor imaging (DTI) and proton magnetic resonance spectroscopy (1H MRS) in schizophrenic subjects and normal controls

1 reference

12 December 2020

Increased GABAA receptor binding in superficial layers of cingulate cortex in schizophrenics

1 reference

12 December 2020

Natural history of schizophrenia subtypes. II. Positive and negative symptoms and long-term course

1 reference

12 December 2020

Increased dopamine transmission in schizophrenia: relationship to illness phases

1 reference

12 December 2020

Combined treatment of schizophrenic psychoses with haloperidol and valproate

1 reference

12 December 2020

The role of N-methyl-D-aspartate (NMDA) receptor-mediated neurotransmission in the pathophysiology and therapeutics of psychiatric syndromes

1 reference

12 December 2020

D-cycloserine added to clozapine for patients with schizophrenia

1 reference

12 December 2020

Multiple fixed doses of "Seroquel" (quetiapine) in patients with acute exacerbation of schizophrenia: a comparison with haloperidol and placebo. The Seroquel Trial 13 Study Group

1 reference

12 December 2020

Medicine. What are the right targets for psychopharmacology?

1 reference

12 December 2020

Biexponential kinetics of [3H]MK-801 binding: evidence for access to closed and open N-methyl-D-aspartate receptor channels

1 reference

12 December 2020

Increased density of entorhinal glutamate-immunoreactive vertical fibers in schizophrenia

1 reference

12 December 2020

The comparative efficacy and long-term effect of clozapine treatment on neuropsychological test performance.

1 reference

12 December 2020

In vivo investigation of white matter pathology in schizophrenia with magnetisation transfer imaging.

1 reference

12 December 2020

[3H]muscimol binding sites increased in autopsied brains of chronic schizophrenics

1 reference

12 December 2020

Expression of excitatory amino acid transporter transcripts in the thalamus of subjects with schizophrenia

1 reference

12 December 2020

An open clinical and biochemical study of ritanserin in acute patients with schizophrenia

1 reference

12 December 2020

Interactive effects of subanesthetic ketamine and subhypnotic lorazepam in humans.

1 reference

12 December 2020

Glial reduction in the subgenual prefrontal cortex in mood disorders

1 reference

12 December 2020

Combinatorial chemistry, automation and molecular diversity: new trends in the pharmaceutical industry

1 reference

12 December 2020

Measurement of GABAergic parameters in the prefrontal cortex in schizophrenia: focus on GABA content, GABA(A) receptor alpha-1 subunit messenger RNA and human GABA transporter-1 (HGAT-1) messenger RNA expression

1 reference

12 December 2020

Selective deficits in prefrontal cortex function in medication-naive patients with schizophrenia.

1 reference

12 December 2020

Low frontal electroencephalographic coherence in neuroleptic-free schizophrenic patients

1 reference

12 December 2020

N-methyl-D-aspartate glutamate receptors and alcoholism: reward, dependence, treatment, and vulnerability

1 reference

12 December 2020

Double-blind, placebo-controlled, crossover trial of glycine adjuvant therapy for treatment-resistant schizophrenia

1 reference

12 December 2020

An integration of 40 Hz Gamma and phasic arousal: novelty and routinization processing in schizophrenia.

1 reference

12 December 2020

Abnormal excitatory neurotransmitter metabolism in schizophrenic brains

1 reference

12 December 2020

Classification of typical and atypical antipsychotic drugs on the basis of dopamine D-1, D-2 and serotonin2 pKi values

1 reference

12 December 2020

Decreased dendritic spine density on prefrontal cortical pyramidal neurons in schizophrenia

1 reference

12 December 2020

Psychiatric Sequelae of Phencyclidine Abuse

1 reference

12 December 2020

Reduced communication between frontal and temporal lobes during talking in schizophrenia

1 reference

12 December 2020

Neuropharmacological profile of non-peptide neurotensin antagonists

1 reference

12 December 2020

Antipsychotic effects of verapamil in schizophrenia

1 reference

12 December 2020

Decreased glutamic acid decarboxylase67 messenger RNA expression in a subset of prefrontal cortical gamma-aminobutyric acid neurons in subjects with schizophrenia

1 reference

12 December 2020

Effects of adjunctive verapamil administration in chronic schizophrenic patients.

1 reference

12 December 2020

A decrease of reelin expression as a putative vulnerability factor in schizophrenia

1 reference

12 December 2020

Genetic and physiological data implicating the new human gene G72 and the gene for D-amino acid oxidase in schizophrenia

1 reference

12 December 2020

Nilvadipine is effective for chronic schizophrenia in a double-blind placebo-controlled study. off

1 reference

12 December 2020

Glycine potentiates the NMDA response in cultured mouse brain neurons

1 reference

12 December 2020

Effects of ketamine on leading saccades during smooth-pursuit eye movements may implicate cerebellar dysfunction in schizophrenia

1 reference

12 December 2020

Work rehabilitation in schizophrenia: does cognitive impairment limit improvement?

1 reference

12 December 2020

[123I]Iomazenil SPECT benzodiazepine receptor imaging in schizophrenia

1 reference

12 December 2020

Mental phenomena evoked by electrical stimulation of the human hippocampal formation and amygdala

1 reference

12 December 2020

Intra- and interhemispheric electroencephalogram coherence in siblings discordant for schizophrenia and healthy volunteers

1 reference

12 December 2020

Subanesthetic doses of ketamine stimulate psychosis in schizophrenia

1 reference

12 December 2020

Pharmacology and functions of metabotropic glutamate receptors

1 reference

12 December 2020

The dissociative anaesthetics, ketamine and phencyclidine, selectively reduce excitation of central mammalian neurones by N-methyl-aspartate

1 reference

12 December 2020

Synaptic basis of cortical persistent activity: the importance of NMDA receptors to working memory.

1 reference

12 December 2020

Glutamate receptor dysfunction and schizophrenia

1 reference

12 December 2020

Hospital use of antipsychotic agents in 1989 and 1993: stable dosing with decreased length of stay

1 reference

12 December 2020

Effects of nifedipine on psychosis and tardive dyskinesia in schizophrenic patients

1 reference

12 December 2020

Negative symptoms: a path analytic approach to a double-blind, placebo- and haloperidol-controlled clinical trial with olanzapine

1 reference

12 December 2020

A placebo-controlled pilot study of the ampakine CX516 added to clozapine in schizophrenia

1 reference

12 December 2020

Effects of amperozide in schizophrenia. An open study of a potent 5-HT2 receptor antagonist

1 reference

12 December 2020

Genome-wide expression analysis reveals dysregulation of myelination-related genes in chronic schizophrenia

1 reference

12 December 2020

Evidence for abnormal cortical functional connectivity during working memory in schizophrenia

1 reference

12 December 2020

Measurement of glutamate and glutamine in the medial prefrontal cortex of never-treated schizophrenic patients and healthy controls by proton magnetic resonance spectroscopy

1 reference

12 December 2020

Natural history of schizophrenia subtypes. I. Longitudinal study of paranoid, hebephrenic, and undifferentiated schizophrenia

1 reference

12 December 2020

Comparative antipsychotic profiles of neurotensin and a related systemically active peptide agonist

1 reference

12 December 2020

Carbamazepine and haloperidol v placebo and haloperidol in excited psychoses. A controlled study

1 reference

12 December 2020

Chronic antipsychotic treatment alters glycine-stimulated NMDA receptor binding in rat brain

1 reference

12 December 2020

Double-blind, placebo-controlled, crossover trial of D-cycloserine adjuvant therapy for treatment-resistant schizophrenia.

1 reference

12 December 2020

Alterations in chandelier neuron axon terminals in the prefrontal cortex of schizophrenic subjects

1 reference

12 December 2020

Effects of ketamine on sensory perception: evidence for a role of N-methyl-D-aspartate receptors

1 reference

12 December 2020

Interhemispheric EEG coherence in never-medicated patients with paranoid schizophrenia: analysis at rest and during photic stimulation

1 reference

12 December 2020

Glutamatergic regulation of basal and stimulus-activated dopamine release in the prefrontal cortex.

1 reference

12 December 2020

MRI white matter diffusion anisotropy and PET metabolic rate in schizophrenia

1 reference

12 December 2020

Involvement of gamma-aminobutyric acid neurotransmission in phencyclidine-induced dopamine release in the medial prefrontal cortex

1 reference

12 December 2020

Potentiation of NMDA and AMPA responses by the specific mGluR5 agonist CHPG in spinal cord motoneurons

1 reference

12 December 2020

Decreased functional connectivity of EEG theta-frequency activity in first-episode, neuroleptic-naïve patients with schizophrenia: preliminary results

1 reference

12 December 2020

Mapping Auditory Hallucinations in Schizophrenia Using Functional Magnetic Resonance Imaging

1 reference

12 December 2020

Increased vertical axon numbers in cingulate cortex of schizophrenics

1 reference

12 December 2020

Differential effects of enrichment on learning and memory function in NR2B transgenic mice

1 reference

12 December 2020

The reduced neuropil hypothesis: a circuit based model of schizophrenia

1 reference

12 December 2020

Nicotinic agonists and psychosis

1 reference

12 December 2020

Attenuation of the neuropsychiatric effects of ketamine with lamotrigine: support for hyperglutamatergic effects of N-methyl-D-aspartate receptor antagonists.

1 reference

12 December 2020

10.1007/S00213-003-1582-Z

Identifiers

DOI

2 references

Consolidated OpenCitations Corpus – April 2017

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12955285%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

7 November 2019

1030311182

0 references

1 reference

Consolidated OpenCitations Corpus – April 2017

2 references

Consolidated OpenCitations Corpus – April 2017

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12955285%20AND%20SRC:MED&resulttype=core&format=json